Literature DB >> 11071263

Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients.

N E Bush1, G W Donaldson, M H Haberman, R Dacanay, K M Sullivan.   

Abstract

Emerging literature suggests that quality of life (QOL) after bone marrow transplantation is relatively good but is accompanied in some patients by a variety of residual difficulties. The studies supporting this finding, however, have been somewhat limited in scale, scope, design, and analysis. We comprehensively measured changes in multidimensional QOL in a 4-year longitudinal follow-up of 415 adult patients who received hematopoietic stem cell transplants at Fred Hutchinson Cancer Research Center. Questionnaire packets containing 271 items were mailed annually posttransplantation to patients' homes. Standard methods of analysis yielded conditional estimates depending on compliance and survival, whereas new, likelihood-based methods generated unconditional estimates applicable to the full intent-to-treat population. Typical QOL levels generally remained high over the entire study period. Most QOL functioning significantly improved over 4 years, with the remainder showing no important decrement. Although isolated problem areas, such as sexual dissatisfaction, did emerge, the level of dysfunction for most physical and psychological scales remained below 30% of scale maxima. Broadly similar results were obtained for conditional estimation, which may contain an optimistic bias, and for unconditional estimation, which largely avoids the bias. Because concurrence was obtained between the 2 types of estimation, we conclude that most patients really do experience good levels of QOL in the 4 years after transplantation. Although some problems can be anticipated, typical patients can look forward to a QOL after transplantation that is broadly comparable to that of the normal population.

Entities:  

Mesh:

Year:  2000        PMID: 11071263     DOI: 10.1016/s1083-8791(00)70067-x

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  27 in total

Review 1.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation.

Authors:  M C Cupit; C Duncan; B N Savani; S K Hashmi
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  Preliminary psychometric evaluation of the Child Health Ratings Inventory (CHRIs) and Disease-Specific Impairment Inventory-Hematopoietic Stem Cell Transplantation (DSII-HSCT) in parents and children.

Authors:  S K Parsons; M C Shih; D K Mayer; S E Barlow; S E Supran; S L Levy; S Greenfield; S H Kaplan
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

3.  Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

Authors:  Can-Lan Sun; Liton Francisco; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

4.  Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.

Authors:  B K Hamilton; A D Law; L Rybicki; D Abounader; J Dabney; R Dean; H K Duong; A T Gerds; R Hanna; B T Hill; D Jagadeesh; M E Kalaycio; C Lawrence; L McLellan; B Pohlman; R M Sobecks; B J Bolwell; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

5.  A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors.

Authors:  Lisa M Wu; Nadia Kuprian; Krista Herbert; Ali Amidi; Jane Austin; Heiddis Valdimarsdottir; Christine Rini
Journal:  Palliat Support Care       Date:  2019-08

6.  Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT).

Authors:  Jumin Park; Leslie Wehrlen; Sandra A Mitchell; Li Yang; Margaret F Bevans
Journal:  Support Care Cancer       Date:  2018-08-22       Impact factor: 3.603

7.  Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib.

Authors:  X-D Mo; Q Jiang; L-P Xu; D-H Liu; K-Y Liu; B Jiang; H Jiang; H Chen; Y-H Chen; X-H Zhang; W Han; Y Wang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

8.  Sleep Patterns During Hospitalization Following Hematopoietic Stem Cell Transplantation.

Authors:  Eileen Danaher Hacker; Mary Catherine Kapella; Chang Park; Carol E Ferrans; Janet L Larson
Journal:  Oncol Nurs Forum       Date:  2015-07       Impact factor: 2.172

9.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

10.  Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.

Authors:  F Lennie Wong; Liton Francisco; Kayo Togawa; Alysia Bosworth; Mitzi Gonzales; Cara Hanby; Melanie Sabado; Marcia Grant; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.